Welcome to the comparator reports webpage.

Here you will find updated information on access to modern pharmacological therapy within different therapeutic areas.

New reports

The objective of this report was to evaluate factors that infuence the diagnosis and treatment 
of rheumatoid arthritis (RA) in five countries (France, Italy, Spain, Germany and the United Kingdom) 
in order to identify potential barriers to treatment access in Europe. Structured desk research was 
consolidated by a number of semi-structured, qualitative telephone interviews with senior treating 
physicians and patient representatives in each country to examine how closely each phase of the 
treatment pathway – diagnosis, treatment and monitoring – followed best-practice recommendations 
by the European League against Rheumatism (EULAR).
Get a copy (pdf)
Summary - France - Italy - Spain - Germany - United Kingdom